Clearmind Medicine Inc (CMND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 10-2024 | 07-2024 | 04-2024 | 01-2024 | 10-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,574 | 7,680 | 8,306 | 9,286 | 5,428 |
| Marketable Securities | 289 | N/A | N/A | 87 | 86 |
| Receivables | 181 | 191 | 175 | 154 | 240 |
| TOTAL | $7,088 | $7,995 | $8,691 | $9,843 | $5,795 |
| Non-Current Assets | |||||
| PPE Net | N/A | 0 | 1 | 1 | 2 |
| Intangibles | 108 | 111 | 114 | 117 | 119 |
| Other Non-Current Assets | 59 | 67 | 40 | 136 | 38 |
| TOTAL | $167 | $179 | $155 | $254 | $159 |
| Total Assets | $7,255 | $8,173 | $8,846 | $10,098 | $5,953 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 575 | 325 | 468 | 761 | 659 |
| Other current liabilities | 3,520 | 4,314 | 3,732 | 4,201 | 4,310 |
| TOTAL | $4,131 | $4,675 | $4,200 | $5,026 | $4,970 |
| Non-Current Liabilities | |||||
| TOTAL | $16 | $26 | $N/A | $31 | $N/A |
| Total Liabilities | $4,148 | $4,700 | $4,200 | $5,056 | $4,970 |
| Shareholders' Equity | |||||
| Common Shares | 24,168 | 23,801 | 22,758 | 22,523 | 17,131 |
| Retained earnings | -24,023 | -23,138 | -21,044 | -20,136 | -18,768 |
| Other shareholders' equity | 2,962 | 2,810 | 2,932 | 2,654 | 2,620 |
| TOTAL | $3,108 | $3,473 | $4,646 | $5,041 | $984 |
| Total Liabilities And Equity | $7,256 | $8,173 | $8,846 | $10,098 | $5,953 |